Trial Profile
Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel [etanercept] in Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Mar 2010 Actual end date (1 Feb 2010) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Actual patient number (231) added as reported by ClinicalTrials.gov.